The main aim of this literature systematic review is to evaluate the current knowledge on the treatment and survival of patients with NF1-associated GBM; we also analyzed genetic data, which could be decisive in defining a multimodal, repeatable, and more effective treatment addressed to this subgroup of GBMs. The gene discussed is NF1; the disease is glioblastoma.